[144] Bausch Health Companies Inc SEC Filing

Rhea-AI Filing Summary

Bausch Health Companies Inc (BHC) filed a Form 144 reporting a proposed sale of 15,912 common shares valued at $121,887.71. The shares were acquired on 05/12/2025 through restricted stock vesting as compensation from the issuer. The filer lists an approximate sale date of 08/21/2025 and the broker named is Fidelity Brokerage Services LLC with execution on the NYSE. The filing states there were 369,790,319 shares outstanding at the time and reports no securities sold by the filer in the prior three months. The notice includes the standard insider representation regarding absence of undisclosed material adverse information.

Positive

• Timely regulatory disclosure: The filer submitted a Form 144 identifying the shares to be sold and broker details.
• Securities originated from compensation: The 15,912 shares were acquired through restricted stock vesting on 05/12/2025, not from an external purchase.

Negative

• Planned insider sale: The filer intends to sell 15,912 common shares with an approximate sale date of 08/21/2025.
• No trading plan date disclosed: The filing does not indicate adoption of a Rule 10b5-1 trading plan or provide a plan adoption date.

Insights

Securities Analyst

TL;DR: Insider plans to sell recently vested restricted shares worth ~$122k, disclosed under Rule 144 for public execution.

This Form 144 reports a routine compliance disclosure: 15,912 shares from restricted stock vesting will be offered for sale using Fidelity as broker on the NYSE with an approximate date of 08/21/2025. The reported aggregate market value is $121,887.71 and the issuer's outstanding shares are listed as 369,790,319. There are no reported sales by the filer in the prior three months. From a trading-impact perspective, the transaction size is modest relative to typical company floats; the filing fulfills regulatory notice requirements without indicating other material events.

Corporate Governance Expert

TL;DR: Disclosure aligns with governance and insider-trading rules; filer affirms no undisclosed material information.

The filing documents that the shares were acquired as compensation via restricted stock vesting on 05/12/2025 and that the filer executed the statutory attestation regarding material information. The inclusion of broker details and the absence of prior sales in the last three months indicate adherence to Rule 144 aggregation and reporting norms. The notice does not disclose any trading plan date or other governance actions beyond the standard representation.

08/21/2025 - 12:24 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	15912	121887.71	369790319	08/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2025	Restricted Stock Vesting	Issuer			15912	05/12/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BHC Form 144 report?

The filing reports a proposed sale of 15,912 common shares valued at $121,887.71, acquired via restricted stock vesting on 05/12/2025.

When is the approximate sale date listed on the BHC Form 144?

The approximate date of sale is listed as 08/21/2025.

Which broker is named for the proposed BHC share sale?

The broker named is Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI 02917).

How many BHC shares were outstanding according to the filing?

The filing lists 369,790,319 shares outstanding.

Did the filer sell any BHC securities in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

How were the shares acquired by the filer?

The shares were acquired on 05/12/2025 via restricted stock vesting from the issuer and paid as compensation.